Management of Patients under Treatment with Monoclonal Antibodies and New Biological Therapies
Objective: The aim of this study is to know the biological therapy drugs that are related to adverse events, what dental treatments are associated with the appearance of these events, their severity, and how they are resolved. Study design: Analysis of cases described in the literature on patients u...
Main Authors: | Marta Amigo-Basilio, Covadonga Álvarez-González, Carlos Cobo-Vázquez, Isabel Leco-Berrocal, Luis Miguel Sáez-Alcaide, Cristina Méniz-García |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/11/11/4865 |
Similar Items
-
Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01) -
DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01) -
Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01) -
Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01) -
Osteonecrosis of jaw associated with bisphosphonate use
by: Ashu Rastogi, et al.
Published: (2012-01-01)